Metabolic Surgery for Obese Type 2 Diabetes: Korean Multicenter Cohort Study
Authors:
- Young Suk ParkYPYoung Suk Park
- Soo Min AhnSASoo Min Ahn
- Sang Hyun KimSKSang Hyun Kim
- Sung Il ChoiSCSung Il Choi
- Kyung Won SeoKSKyung Won Seo
- Han Hong LeeHLHan Hong Lee
- Youngsung SuhYSYoungsung Suh
- Ji Yeon ParkJPJi Yeon Park
- Sang Eok LeeSLSang Eok Lee
- Sungsoo ParkSungsoo Park
- Dong Jin KimDong Jin Kim
- In ChoICIn Cho
Open Access
- 13 November 2025
- journal article
- research article
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (12) , 5441-5451
Abstract
Background: Metabolic/bariatric surgery is an effective treatment for obesity and type 2 diabetes mellitus (T2DM), with sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) being the most common procedures. However, comparative data on their metabolic benefits in East Asian populations are limited. Methods: This multicenter retrospective cohort study assessed outcomes of SG and RYGB in Korean adults (BMI ≥ 30 kg/m²) with T2DM who underwent surgery between January 2019 and June 2021. The primary outcome was complete T2DM remission at 1 and 2 years postoperatively. Follow-up data were available for 271 patients at 1 year and 169 at 2 years. Results: Unadjusted analysis showed lower complete remission rates in the RYGB group than the SG group at both 1 year (51.4% vs. 66.3%, p = 0.029) and 2 years (50.0% vs. 62.9%, p = 0.033). After adjustment using inverse probability of treatment weighting (IPTW), the pattern reversed in favor of RYGB (1 year: 67.5% vs. 48.2%; 2 years: 64.4% vs. 46.9%), though differences were not statistically significant ( p = 0.127 and p = 0.373). Multivariable logistic regression identified shorter duration of T2DM and absence of insulin use as independent predictors of remission; surgical procedure type was not. Conclusions: After adjusting for baseline differences, no statistically significant difference in T2DM remission was observed between SG and RYGB at 1 and 2 years in Korean patients with BMI ≥ 30 kg/m². These findings should be interpreted with caution given the modest sample size and limited follow-up. Prospective studies are needed to validate these findings and support clinical decision-making.Keywords
Funding Information
- Seoul National University
This publication has 33 references indexed in Scilit:
- Clinical Outcomes of Resectional Roux-en-Y Gastric Bypass, Compared to Sleeve Gastrectomy for Severe ObesityObesity Surgery, 2023
- 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric SurgeryObesity Surgery, 2022
- Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss, Comorbidities, and Reflux at 10 Years in Adult Patients With ObesityJAMA Surgery, 2022
- Efficacy of Different Procedures of Metabolic Surgery for Type 2 Diabetes in Asia: a Multinational and Multicenter Exploratory StudyObesity Surgery, 2021
- A Comprehensive Comparison of LRYGB and LSG in Obese Patients Including the Effects on QoL, Comorbidities, Weight Loss, and Complications: a Systematic Review and Meta-AnalysisObesity Surgery, 2019
- Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid ObesityJAMA, 2018
- Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid ObesityJAMA, 2018
- Predictors of Long-Term Diabetes Remission After Metabolic SurgeryJournal of Gastrointestinal Surgery, 2015
- Standardized Outcomes Reporting in Metabolic and Bariatric SurgeryObesity Surgery, 2015
- Gastric Bypass vs Sleeve Gastrectomy for Type 2 Diabetes MellitusArchives of Surgery, 2011